Switzerland's Vaccine and Antibiotic Supply Improves, Severe Shortage Officially Ends

On Monday local time, the Swiss federal government officially stated that the supply of vaccines and antibiotics in the country is continuously improving, and these two key medical products are no longer facing severe shortages, marking a phased progress in Switzerland's medical supplies guarantee. 

However, the federal government also admitted that the supply of some other domestic drugs is still tight, and the balance of overall medical supplies needs to be further promoted.

In a statement released on the same day, the Swiss Federal Office for Economic Supply (OFAE) clearly pointed out that the reserved vaccines and antibiotics previously requisitioned to address the shortage have now been almost fully replenished. 

This achievement directly marks the official end of the severe shortage of these two types of products, providing an important guarantee for the stable operation of Switzerland's medical system.

It is reported that since 2019, the supply of vaccines and antibiotics in Switzerland has been tight. To effectively alleviate this problem, the Swiss federal government has gradually unfrozen a number of mandatory reserve funds, which are specifically used to address the shortage of these two types of products, and the relevant response measures have achieved remarkable results. 

With the improvement of supply, the relevant legal orders formulated earlier to deal with the shortage will be officially abolished on March 1.

It should be noted that although the supply of vaccines and antibiotics has been significantly improved, the overall drug supply situation in Switzerland is still not optimistic. 

The Federal Office for Economic Supply (OFAE) stated that there are still dozens of drugs in the country that cannot be supplied normally, and the problem of tight supply has not been completely solved. Relevant departments are still continuously promoting various guarantee measures to fully ease the pressure on drug supply.

As a country with a relatively developed global pharmaceutical industry, Switzerland's previous drug supply shortage was mainly affected by multiple factors such as the fragility of the global supply chain and market scale. 

The improvement in the supply of vaccines and antibiotics this time not only eases the pressure on the local medical system but also accumulates experience for solving the tight supply of other drugs in the future. 

At present, relevant Swiss departments are continuously monitoring the drug supply dynamics, taking various measures to ensure the stable supply of various medical supplies, and effectively safeguarding the medical needs of the public.